KCI Holdings, an LBO’d provider of advanced wound care systems and tissue implants, filed on Thursday with the SEC to raise up to $500 million in an initial public offering.
The San Antonio, TX-based company was founded in 1976 and booked $1.5 billion in sales for the 12 months ended December 31, 2018. It plans to list on the NYSE under the symbol KCIH.RC. KCI Holdings filed confidentially on February 14, 2019. J.P. Morgan, Goldman Sachs and BofA Merrill Lynch are the joint bookrunners on the deal. No pricing terms were disclosed.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.